The firm’s long history of private equity in the healthcare industry and our deep domain knowledge create opportunities to partner with exceptional management leaders and to generate unique perspective on the underlying trends that drive the healthcare industry today.

There are critical factors to be weighed for private equity investment in healthcare. GTCR has extensive experience in private equity investing across the healthcare services and life sciences industries, including branded and generic pharmaceuticals, medical devices, life science tools and diagnostics, healthcare information technology, providers, payors, distribution and ancillary services. We continue to identify attractive opportunities in healthcare investment driven by the positive, long-term healthcare utilization trends and an evolving industry landscape that increasingly values new business models that emphasize both clinical outcomes and cost-containment.